Senores Pharmaceuticals L share price
SENORES on NSE · data as of 16 Oct 2026
Senores Pharmaceuticals L closed at ₹1,318.40 on 16 Oct 2026 (+4.73% on the day). It is 17.5% below its 52-week high of ₹1,599.00 (24 Aug 2026) and 88.1% above its 52-week low of ₹700.75 (8 Oct 2025). The stock has outperformed the Nifty 50 over the past year (+80.1% vs -8.5%). It is above its 200-day average but below its 50-day average (a pullback within a longer uptrend), with RSI 45 (neutral zone).
Where the price sits
Last 12 months
Weekly closing prices, adjusted for splits and bonus issues.
Returns vs Nifty 50
| Period | SENORES | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | −0.1% | +2.8% | −2.9 pts |
| 1 month | −4.2% | −0.3% | −3.9 pts |
| 3 months | −6.2% | −4.9% | −1.3 pts |
| 6 months | +48.1% | −4.3% | +52.4 pts |
| 1 year | +80.1% | −8.5% | +88.6 pts |
Trend and activity
- 50-day average: ₹1,419.02 (price below)
- 200-day average: ₹1,096.32 (price above)
- RSI (14 days): 45
- Turnover on 16 Oct 2026: ₹37.1 cr (1.2x the 20-day average volume)
New to these terms? See 52-week high, moving average and RSI.
Quick answers
What is the 52-week high of Senores Pharmaceuticals L?
The 52-week high of Senores Pharmaceuticals L (SENORES) is ₹1,599.00, reached on 24 Aug 2026. The 52-week low is ₹700.75, on 8 Oct 2025 (NSE, as of 16 Oct 2026).
How has Senores Pharmaceuticals L performed in the last year?
Over the last year the share price has moved +80.1%, compared with -8.5% for the Nifty 50 (as of 16 Oct 2026). Past returns do not predict future returns.
Is Senores Pharmaceuticals L in an uptrend?
As of 16 Oct 2026, Senores Pharmaceuticals L is above its 200-day average but below its 50-day average (a pullback within a longer uptrend), with RSI 45 (neutral zone). Trend describes the past, not what happens next.
Price facts only, refreshed every trading day. Not a recommendation to buy or sell. Education only. Not investment advice. All stocks · Today's stock lists